ELIZABETH DARGIS: Open Payments
NPI 1457986218 · SALEM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 25 payments from 11 companies in 2025. Trend: 2023 $732 · 2024 $828 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $171 |
| Novo Nordisk Inc | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Lundbeck LLC | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Amgen Inc. | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: VRAYLAR, Wegovy, VOQUEZNA, CAPLYTA, REXULTI, QULIPTA, RECORLEV, REPATHA.
Industry payments across NH — which companies pay providers there.
